EP3533777A4 - Composé acétate d'ordre élevé, et agent solide de dialyse mettant en ouvre celui-ci - Google Patents

Composé acétate d'ordre élevé, et agent solide de dialyse mettant en ouvre celui-ci Download PDF

Info

Publication number
EP3533777A4
EP3533777A4 EP17863627.0A EP17863627A EP3533777A4 EP 3533777 A4 EP3533777 A4 EP 3533777A4 EP 17863627 A EP17863627 A EP 17863627A EP 3533777 A4 EP3533777 A4 EP 3533777A4
Authority
EP
European Patent Office
Prior art keywords
same
acetate compound
dialysis agent
solid dialysis
order acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17863627.0A
Other languages
German (de)
English (en)
Other versions
EP3533777A1 (fr
EP3533777B1 (fr
Inventor
Yusuke Yoshimoto
Junya Kikuishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tomita Pharmaceutical Co Ltd
Original Assignee
Tomita Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomita Pharmaceutical Co Ltd filed Critical Tomita Pharmaceutical Co Ltd
Publication of EP3533777A1 publication Critical patent/EP3533777A1/fr
Publication of EP3533777A4 publication Critical patent/EP3533777A4/fr
Application granted granted Critical
Publication of EP3533777B1 publication Critical patent/EP3533777B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08—Acetic acid
    • C07C53/10—Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08—Acetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
EP17863627.0A 2016-10-28 2017-02-24 Composé acétate d'ordre élevé, et agent solide de dialyse mettant en ouvre celui-ci Active EP3533777B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016212312 2016-10-28
PCT/JP2017/007248 WO2018078901A1 (fr) 2016-10-28 2017-02-24 Composé acétate d'ordre élevé, et agent solide de dialyse mettant en œuvre celui-ci

Publications (3)

Publication Number Publication Date
EP3533777A1 EP3533777A1 (fr) 2019-09-04
EP3533777A4 true EP3533777A4 (fr) 2020-06-17
EP3533777B1 EP3533777B1 (fr) 2023-07-26

Family

ID=62024547

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17863627.0A Active EP3533777B1 (fr) 2016-10-28 2017-02-24 Composé acétate d'ordre élevé, et agent solide de dialyse mettant en ouvre celui-ci

Country Status (5)

Country Link
EP (1) EP3533777B1 (fr)
KR (1) KR102678681B1 (fr)
CN (1) CN109843845B (fr)
MY (1) MY196043A (fr)
WO (1) WO2018078901A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892397A (zh) * 2015-04-02 2015-09-09 秦健 制造双乙酸钠的方法
US20160272566A1 (en) * 2013-11-12 2016-09-22 Fuso Pharmaceutical Industries, Ltd. Novel sodium diacetate crystal and solid dialysis preparation comprising said crystal

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517321B2 (fr) 1973-06-06 1980-05-10
JPS5099464U (fr) 1974-01-16 1975-08-18
JPS5517321U (fr) 1978-07-18 1980-02-04
JP3433979B2 (ja) 1993-08-24 2003-08-04 日機装株式会社 透析用剤及びその製造方法
JPH0782209A (ja) * 1993-09-10 1995-03-28 Oogaki Kasei Kogyo Kk 品質の改善された酢酸ナトリウム３水塩の製造方法
WO2004067014A1 (fr) * 2003-01-31 2004-08-12 Manac Inc. Preparation solide destinee a la dialyse et procede de fabrication correspondant
JP4989876B2 (ja) * 2005-11-09 2012-08-01 マナック株式会社 透析用固形剤およびその製造方法
JP5099464B1 (ja) 2011-12-29 2012-12-19 富田製薬株式会社 重炭酸イオン濃度可変型の透析液の調製装置及び調製方法、重炭酸イオン濃度可変型の透析剤、並びに重炭酸イオン濃度可変型の透析システム
WO2014017594A1 (fr) * 2012-07-26 2014-01-30 久光製薬株式会社 Timbre adhésif
JP5376480B1 (ja) * 2012-10-10 2013-12-25 富田製薬株式会社 酢酸及び酢酸塩を含む透析用ａ剤、及びそれを用いた２剤型透析用剤
JP2016153391A (ja) 2015-02-16 2016-08-25 日本合成化学工業株式会社 無水酢酸ナトリウム結晶
JP6931179B2 (ja) * 2015-05-18 2021-09-01 三菱ケミカル株式会社 無水酢酸ナトリウム結晶の製造方法及び無水酢酸ナトリウム結晶

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160272566A1 (en) * 2013-11-12 2016-09-22 Fuso Pharmaceutical Industries, Ltd. Novel sodium diacetate crystal and solid dialysis preparation comprising said crystal
CN104892397A (zh) * 2015-04-02 2015-09-09 秦健 制造双乙酸钠的方法

Also Published As

Publication number Publication date
EP3533777A1 (fr) 2019-09-04
KR20190077354A (ko) 2019-07-03
MY196043A (en) 2023-03-09
CN109843845B (zh) 2022-02-18
KR102678681B1 (ko) 2024-06-25
WO2018078901A1 (fr) 2018-05-03
EP3533777B1 (fr) 2023-07-26
CN109843845A (zh) 2019-06-04

Similar Documents

Publication Publication Date Title
EP3624751A4 (fr) Systèmes à redressement automatique, procédés et composants associés
EP3665156A4 (fr) Composés, compositions et procédés
EP3564237A4 (fr) Composé d'urée, son procédé de préparation et son application
EP3676297A4 (fr) Composés, compositions et procédés
EP3293226A4 (fr) Composition de plastifiant et composition de résine la comprenant
EP3274038A4 (fr) Systèmes, dispositifs et procédés d'articulation pour cathéters et autres utilisations
EP3497087A4 (fr) Entités chimiques, compositions et méthodes particulières
EP3270694A4 (fr) Entités chimiques, compositions et méthodes particulières
EP3313530A4 (fr) Dérivés de 4,6-pyrimidinylène et utilisations de ceux-ci
EP3255897A4 (fr) Procédé et terminal permettant de configurer un écouteur à réduction du bruit et écouteur à réduction de bruit
EP3263122A4 (fr) Peptide pour prévenir la perte de l'audition et composition le comprenant
EP3387196A4 (fr) Systèmes d'attache poutre-poteau et charpentes résistantes aux moments et comportant ces systèmes
EP3307374A4 (fr) Systèmes, dispositifs et procédés d'hémodialyse à orifice de greffon
EP3424924A4 (fr) Composé d'urée, son procédé de préparation et son utilisation médicale
EP3246327A4 (fr) Dérivé 3-acétylényle-pyrazole-pyrimidine, méthode de préparation et utilisations correspondantes
EP3640248A4 (fr) Composé aminopyrimidine, son procédé de préparation et son utilisation
EP3248636A4 (fr) Ensemble filtre pour seringue, seringue et ensemble anneau le comprenant
EP3556769A4 (fr) Dérivé de polyximine, procédé de préparation et application associés
EP3884065A4 (fr) Procédés, systèmes et compositions de bibliothèque directe
EP3722395A4 (fr) Composé inhibant le frottement, et composition inhibant le frottement comprenant celui-ci
EP3406602A4 (fr) Composé 1-sulfonamido-4-aryloxy, son procédé de préparation et son application médicinale
EP3552017A4 (fr) Composés, compositions et méthodes
EP3715342A4 (fr) Composé contenant du fluorosulfonyle, intermédiaire de celui-ci, procédé de préparation associé et utilisation correspondante
EP3415873A4 (fr) Structure de rotation, système d'assistance, et robot
EP3514155A4 (fr) Composé hétérocyclique et agent de lutte contre les arthropodes nuisibles le contenant

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190509

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602017071927

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: C07C0053080000

Ipc: C07C0053100000

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C07C0053080000

Ipc: C07C0053100000

A4 Supplementary search report drawn up and despatched

Effective date: 20200520

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 51/43 20060101ALI20200514BHEP

Ipc: C07C 53/08 20060101ALI20200514BHEP

Ipc: A61K 47/12 20060101ALI20200514BHEP

Ipc: A61P 7/08 20060101ALI20200514BHEP

Ipc: C07C 53/10 20060101AFI20200514BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230221

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017071927

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20230726

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1591811

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231027

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231127

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231026

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231126

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231027

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017071927

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240122

Year of fee payment: 8

Ref country code: GB

Payment date: 20240122

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240122

Year of fee payment: 8

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20240429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230726

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240229